AI Generated Image
Coroner Links California Law Student’s Death To Weight Loss Drug Tirzepatide
Where Is The Buzz • • health
Key Points:
- Josephine Nasr, a 19-year-old American law student in England, died from a heart rhythm disturbance linked to myocardial bridging and electrolyte imbalance caused by the weight-loss drug tirzepatide.
- The coroner found that tirzepatide-induced nausea led to hypoglycemia and electrolyte imbalance, triggering a dangerous arrhythmia in Nasr, who had a congenital heart condition.
- Nasr was otherwise healthy but experienced severe nausea and vomiting on the night of her death, leading to dehydration; she was found unresponsive and declared dead at her student accommodation.
- Tirzepatide, marketed as Mounjaro and Zepbound for diabetes and weight management, carries warnings about serious side effects like gastrointestinal reactions and is not approved for cosmetic weight loss or use in those under 18.
- Nasr’s family described her as a joyful and caring young woman, mourning her unexpected death and highlighting her active, compassionate nature.
